INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1818604
ORLANDO, FL
Position in NBIX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$19,045
+$13,644 QoQ
Shares Held
113
+175.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#155
of 205 holders
Holding Since
Dec 2020
8 quarters on record
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC holds $761,060 across 10 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
6,561 | $471,473 | |
| 2 | AQST |
Aquestive Therapeutics, Inc.
|
21,595 | $89,835 | |
| 3 | VTRS |
Viatris Inc
|
3,251 | $51,625 | |
| 4 | CRON |
Cronos Group Inc.
|
16,300 | $45,314 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
81 | $43,888 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
900 | $31,203 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
113 | $19,045 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
1,737 | $7,799 |
All Filings in NBIX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,045 | 113 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $5,401 | 41 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $6,666 | 47 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $246,226 | 1,754 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $220,460 | 1,754 | Shares | Sole | 2025-07-29 | |
| 2024-06-30 | $2,340 | 17 | Shares | Sole | 2024-07-30 | |
| 2021-03-31 | $778 | 8 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $766 | 8 | Shares | Sole | 2021-04-19 | |
| No filing history on record for this holder in this stock. | ||||||